Education
About Us
Working with TipRanks
Follow Us
Kathleen D. Scott Insider Profile
4 Followers
Kathleen D. Scott, Director at Histogen, holds ― shares in Histogen (Ticker: HSTOQ), holds 18.29K shares in ARS Pharmaceuticals (Ticker: SPRY), holds 29.58K shares in Dermata Therapeutics (Ticker: DRMA). Most recently, Kathleen D. Scott ― shares of Histogen on ― for an estimated value of ―.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+9.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kathleen D. Scott holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kathleen D. Scott
Kathleen D. Scott's Trading History
Histogen
―
―
―
―
Dermata Therapeutics
Oct 07, 2022
Director
Uninformative Buy
―
$36.09K
ARS Pharmaceuticals
Aug 22, 2025
CFO
Uninformative Buy
18.75K
$162.62K
NKGen Biotech
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Kathleen D. Scott's performance on stock
You May Also Like
Kathleen D. Scott insider profile FAQ
What is the percentage of profitable transactions made by Kathleen D. Scott?
The percentage of profitable transactions made by Kathleen D. Scott is 50%.
What is the average return per transaction made by Kathleen D. Scott?
The average return per transaction made by Kathleen D. Scott is 9.30%.
What stocks does Kathleen D. Scott hold?
Kathleen D. Scott holds: HSTOQ, DRMA, SPRY, NKGN stocks.
What was Kathleen D. Scott’s latest transaction?
Kathleen D. Scott latest transaction was an Uninformative Buy of ―.
What was Kathleen D. Scott's most profitable transaction?
Kathleen D. Scott’s most profitable transaction was an Informative Sell of SPRY stock on May 22, 2025. The return on the trade was 42.20%.
What is Kathleen D. Scott's role in Histogen?
Kathleen D. Scott's role in Histogen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.